论文部分内容阅读
截止1987年,作者对88例食管癌术前给高温、化疗和放射(HCR 疗法),对照组122例术前单放疗或并用化疗(CR 疗法),评价组织学疗效和生存率。对不能手术切除的 HCR 组和 CR 组各30例,治疗前后做食道钡餐透视,评定肿瘤缩小率及生存率,并分析 HCR 组47例病人热敏感试验与临床 X 线疗效的关系。方法:放疗1.5～2.0Gy/次,第1到第5天,休2天,连用3周,总量30Gy。放疗1小时后,采用 RF 射频电容式食管腔内加温,频率13.56MHz,最大输出功率250W,温度42～45℃,30分/次,第1,5天各一次;同时在每次加温前给平阳霉素5mg/次,第1,4天各一次,连用3周。热疗共6次,平阳霉素总量30mg,或 DDP50mg/次,第1,8,15天静滴,总
As of 1987, the authors evaluated the histological efficacy and survival rate of 88 cases of esophageal carcinoma given preoperative hyperthermia, chemotherapy, and radiation (HCR therapy), and the control group of 122 cases of pre-operative single or combined chemotherapy (CR). For the unresectable HCR group and CR group, 30 cases were treated with esophageal barium meal before and after treatment to assess tumor shrinkage and survival rate. The relationship between heat sensitivity test and clinical X-ray efficacy in 47 patients in the HCR group was analyzed. Methods: Radiotherapy 1.5 ~ 2.0Gy / time, the first to the fifth day, rest 2 days, once every 3 weeks, total 30Gy. After 1 hour of radiotherapy, RF RF-capacitive esophageal cavity was used for heating, frequency 13.56MHz, maximum output power 250W, temperature 42-45°C, 30 minutes/time, once on the first and fifth days; Pingyangmycin 5mg/time before warming, once on the first and fourth days, once every 3 weeks. A total of 6 times of hyperthermia, the total amount of Pingyangmycin 30mg, or DDP50mg/time, the first 1,8, 15 days of intravenous infusion, total